Drug research efficiency Tamsin Fortе in the treatment of men with symptomatic benign prostatic hyperplasia

##plugins.themes.bootstrap3.article.main##

І. І. Горпинченко
Ю. М. Гурженко
В. В. Спиридоненко
С. А. Костюченко
В. М. Красовський

Abstract

The paper evaluated the effectiveness of treatment with Tamsin Forte in 55 patients with benign prostatic hyperplasia stage II. The effectiveness of drug treatment was 92,8%.

##plugins.themes.bootstrap3.article.details##

How to Cite
Горпинченко, І. І., Гурженко, Ю. М., Спиридоненко, В. В., Костюченко, С. А., & Красовський, В. М. (2017). Drug research efficiency Tamsin Fortе in the treatment of men with symptomatic benign prostatic hyperplasia. Health of Man, (1(60), 79–81. https://doi.org/10.30841/2307-5090.1(60).2017.115341
Section
Urology
Author Biographies

І. І. Горпинченко, ГУ «Институт урологии НАМН Украины», г. Киев

I.I. Gorpynchenko

Ю. М. Гурженко, ГУ «Институт урологии НАМН Украины», г. Киев

Y.N. Gurzhenko

В. В. Спиридоненко, ГУ «Институт урологии НАМН Украины», г. Киев

V.V. Spiridonenko

С. А. Костюченко, Городская клиническая больница No 1, г. Винница

S.A. Kostyuchenko

В. М. Красовський, ГУ «Институт урологии НАМН Украины», г. Киев

V.M. Krasovskiy

References

Wilde MI and McTavish D. Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia / Drugs 1996; 52: 883-898.

Wolzt M, Fabrizii V, Dorner GT, Zanaschka G, Leufkens P, Krauwinkel WJ, and Eichler HG. Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study / Eur J Clin Pharmacol 1998; 54: 367-373.

Dunn CJ, Matheson A, and Faulds DM. Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms / Drugs Aging 2002; 19: 135-161.

Andersson KE. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists/ World J Urol 2002; 19: 390-96

Miyazawa Y, Forrest A, Schentag JJ, Kamimura H, Swarz H, and Ito Y. Effect of concomitant administration of cimetidine hydrochloride on the pharmacokinetic and safety profile of Tamsulosin hydrochloride 0.4 mg in healthy subjects / Current Therapeutic Research 2002; 63: 15-26.

Maruenda J, Bhatnagar V, and Lowenthal DT. Hypertension in the elderly with coexisting benign prostatic hyperplasia / Urology. 1999; 53: 7-12.

Lowe FC. Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect / Clin Ther 1997; 19: 730-742.

Мiyazawa Y, Blum RA, Schentag JJ, Kamimura H, Matsushima H, Swarz H, and Ito Y. Pharmacokinetics and safety of tamsulosin in subjects with normal and impaired renal or hepatic function/ Current Therapeutic Research 2001; 62: 603-621.